Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Part of the Mycota brand family (generic: Undecenoic acid + Dichlorophen)
MHRA licensed products
View all licensed products for Undecenoic acid + Dichlorophen on the MHRA register
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 30 studies.
Reviews & meta-analyses: 1 · 2014–2024
Showing all 30 studies, sorted by most relevant.
S. Fernandes, A. Borges, I. Gomes, et al.
Food research international, 2023
- Curcumin
- Quorum Sensing
- Pioglitazone
The quorum sensing (QS) system is related to cell-to-cell communication as a function of population density, which regulates several physiological functions including biofilm formation and virulence gene expression. QS inhibitors have emerged as a promising strategy to tackle virulence and biofilm development. Among a wide variety of phytochemicals, many of them have been described as QS inhibitors. Driven by their promising clues, this study aimed to identify active phytochemicals against LuxS/autoinducer-2 (AI-2) (as the universal QS system) from Bacillus subtilis and LasI/LasR (as a specific QS system) of Pseudomonas aeruginosa, through in silico analysis followed by in vitro validation. The optimized virtual screening protocols were applied to screen a phytochemical database containing 3479 drug-like compounds. The most promising phytochemicals were curcumin, pioglitazone hydrochloride, and 10-undecenoic acid. In vitro analysis corroborated the QS inhibitory activity of curcumin and 10-undecenoic acid, however, pioglitazone hydrochloride showed no relevant effect. Inhibitory effects on LuxS/AI-2 QS system triggered reduction of 33-77% by curcumin (at 1.25-5 µg/mL) and 36-64% by 10-undecenoic acid (at 12.5-50 µg/mL). Inhibition of LasI/LasR QS system was 21% by curcumin (at 200 µg/mL) and 10-54% by 10-undecenoic acid (at 15.625-250 µg/mL). In conclusion, in silico analysis allowed the identification of curcumin and, for the first time, 10-undecenoic acid (showing low cost, high availability, and low toxicity) as alternatives to counteract bacterial pathogenicity and virulence, avoiding the imposition of selective pressure usually related to classic industrial disinfection and antibiotics therapy.
Abstract licence: CC BY-NC-ND
A. M. Api, D. Belsito, D. Botelho, et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018
- Esters
- Odorants
- Perfume
C.A. Ospina-Delacruz, V. Castillo-Gallardo, D. Ariza-Flores, et al.
Materials Letters, 2023
N. Lamba, R. Narayan, J. Modak, et al.
Journal of Supercritical Fluids, 2016
M. Cerrada, A. Bento, E. Pérez, et al.
Catalysts, 2023
Functionalized polyethylene-based nanocomposites were prepared by in situ polymerization of ethylene with modified or neat MCM-41 nanoparticles (NMCM-41). Two different synthetic approaches were investigated to improve the compatibility between the hydrophobic HDPE matrix and the hydrophilic NMCM-41: (i) incorporation of UA into the polymeric matrix by copolymerization with ethylene, promoted by the zirconocene catalyst under homogeneous conditions, in the presence of pristine NMCM-41; (ii) use of undecenoic acid (UA) as an interfacial agent to obtain decorated NMCM-41 to be used as nanofiller for the in situ ethylene polymerization, catalyzed by Cp2ZrCl2/MAO under supported conditions. The strong polar character of the carboxylic group is expected to either increase the hydrophilicity of the HDPE chains (strategy i) or interact with the NMCM-41 surface and provide an additional link to the polymeric chains via copolymerization of the vinyl group under supported conditions (strategy ii). Although metallocene catalysts have been shown to copolymerize olefins with functional monomers, the presence of oxygen-containing compounds in the reaction media strongly affects the polymerization activity as a result of the interaction of functional groups with the electrophilic active center of the catalyst. Thus, UA was pre-contacted with tri(isobutyl)aluminum (TIBA) prior to its use in the polymerization to reduce the deactivating character of the carboxylic acid groups towards the zirconocene catalyst. The influence of the UA presence on the polymerization behavior of the protection step is discussed, and the polymerization activities observed for the different approaches are compared. In addition, the thermal behavior and structural details of the resulting materials have been characterized. The impact of using neat or functionalized NMCM-41 on the final dispersion within the polymeric matrix is also analyzed, which is correlated with the mechanical performance exhibited by these HDPE_UA_NMCM-41 nanocomposites.
Abstract licence: CC BY
A. M. Api, A. Bartlett, D. Belsito, et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2024
B. Gandhi, K. Greeshma, Durga Prasad Ruvulapalli, et al.
Medicinal Chemistry Research, 2023
Sathyam Reddy Yasa, Snehalatha Cheguru, S. Krishnasamy, et al.
Industrial Crops and Products, 2017
Naganna Narra, S. Kaki, R. Prasad, et al.
Beilstein Journal of Organic Chemistry, 2017
The synthesis of five novel methyl 10-undecenoate-based lipoconjugates of phenolic acids from undecenoic acid was carried out. Undecenoic acid was methylated to methyl 10-undecenoate which was subjected to a thiol–ene reaction with cysteamine hydrochloride. Further amidation of the amine was carried out with different phenolic acids such as caffeic, ferulic, sinapic, coumaric and cinnamic acid. All synthesized compounds were fully characterized and their structures were confirmed by spectral data. The anti-oxidant activity of the synthesized lipoconjugates of phenolic acids was studied by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay and also by the inhibition of linoleic acid oxidation in micellar medium by differential scanning calorimetry (DSC). The prepared compounds were also screened for their cytotoxic activity against five cell lines. It was observed that the lipoconjugates of caffeic acid, sinapic acid, ferulic acid, and coumaric acid displayed anticancer and anti-oxidant properties. The anticancer properties of these derivatives have been assessed by their IC 50 inhibitory values in the proliferation of MDA-MB231, SKOV3, MCF7, DU 145 and HepG2 cancer cell lines.
Abstract licence: CC BY
C. Valverde, Gerard Lligadas, J. C. Ronda, et al.
Polymer Degradation and Stability, 2018
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.